EUVIMEDEUVIMED entdecken
Multizentrische Studie

Textbook outcomes of hepatocellular carcinoma patients with sarcopenia: A multicenter analysis

Di-Hang Wu, Cheng-Yu Liao, Dan-Feng Wang, Long Huang, Ge Li, Jiang-Zhi Chen, Liang Wang, Tian-Sheng Lin, Jian-Lin Lai, Song-Qiang Zhou, Fu-Nan Qiu, Zhi-Bo Zhang und 5 weitere

European Journal of Surgical Oncology · 2023-04 · 49 (4) · 802-810

DOI: 10.1016/j.ejso.2022.12.009 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Surgical Oncology, 2023-04. Verfasst von Di-Hang Wu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospi…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Sarcopenia. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The impact of sarcopenia on textbook outcome (TO) after hepatectomy in hepatocellular carcinoma (HCC) patients remains unclear. This study aimed to investigate the association between sarcopenia and TO, to clarify its long and short-term prognostic value, and to develop a nomogram model based on sarcopenia and TO for survival prediction. METHODS: Patients who underwent HCC resection between January 2012 and March 2017 in three large hospitals in Fujian were retrospectively recruited and divided into sarcopenia and non-sarcopenia groups based on skeletal muscle index (SMI) values. TO was defined as no 30-day morality, no 30-day readmission, negative margins, no prolonged hospital stay, and no major complications. Multivariate regression was used to screen for clinical factors associated with TO. Nomograms of overall survival (OS) and recurrence-free survival (RFS) after hepatectomy for HCC were developed. RESULTS: A total of 1172 patients were included in the study. The TO rates were 28.74% (121/421 patients) in the sarcopenia group and 43.4% (326/751 patients) in the non-sarcopenia group. The results showed that sarcopenia was an independent predictor of TO (p < 0.001), TO was an independent predictor of perioperative treatment-related sarcopenia (PTRS)(p = 0.002), and TO was an independent predictor of OS and RFS (p < 0.001). Nomogram models based on sarcopenia and TO were generated and accurately predicted OS and RFS at 1, 3, and 5 years. CONCLUSION: Both sarcopenia and TO are independent predictors of OS and RFS after HCC resection. Sarcopenia was an independent predictor of TO. Sarcopenia influenced long-term survival by affecting short-term postoperative outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsSarcopeniaHumansRetrospective StudiesPrognosisNomogramsHepatectomy

Stichwörter der Autor:innen

HepatectomyHepatocellular carcinomaSarcopeniaTextbook outcome

Autor:innen und Institutionen

  • Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou, China.
  • Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China; Department of Anesthesiology, Fujian Provincial Hospital, Fuzhou, China.
  • Fujian Medical University Union Hospital, Fuzhou, China.
  • The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  • Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou, China. Electronic address: tianyifengfz@126.com.
  • Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou, China. Electronic address: wawljwalj@163.com.

Zitieren

APA

Wu, D. H., Liao, C. Y., Wang, D. F., Huang, L., Li, G., Chen, J. Z., Wang, L., Lin, T. S., Lai, J. L., Zhou, S. Q., Qiu, F. N., Zhang, Z. B., Chen, Y. L., Wang, Y. D., Zheng, X. C., Tian, Y. F., & Chen, S. (2023). Textbook outcomes of hepatocellular carcinoma patients with sarcopenia: A multicenter analysis. European Journal of Surgical Oncology, 49(4), 802-810. https://doi.org/10.1016/j.ejso.2022.12.009

Vancouver

Wu DH, Liao CY, Wang DF, Huang L, Li G, Chen JZ, et al. Textbook outcomes of hepatocellular carcinoma patients with sarcopenia: A multicenter analysis. European Journal of Surgical Oncology. 2023;49(4):802-810. doi:10.1016/j.ejso.2022.12.009

BibTeX
@article{Wu2023,
  author = {Wu, Di-Hang and Liao, Cheng-Yu and Wang, Dan-Feng and Huang, Long and Li, Ge and Chen, Jiang-Zhi and Wang, Liang and Lin, Tian-Sheng and Lai, Jian-Lin and Zhou, Song-Qiang and Qiu, Fu-Nan and Zhang, Zhi-Bo and Chen, Yan-Ling and Wang, Yao-Dong and Zheng, Xiao-Chun and Tian, Yi-Feng and Chen, Shi},
  title = {Textbook outcomes of hepatocellular carcinoma patients with sarcopenia: A multicenter analysis},
  journal = {European Journal of Surgical Oncology},
  year = {2023},
  volume = {49},
  number = {4},
  pages = {802--810},
  doi = {10.1016/j.ejso.2022.12.009}
}
Kostenlos starten →